Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
Dr. Franziska Hopfner talks about the main takeaways from her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Neurology Minute","authorlink":""},"src":"http:\/\/traffic.libsyn.com\/neurologyminute\/July_9_2019_FAI_NM_Ratliff__Hopfner.mp3?dest-id=1085030","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202109\/c33030-202f-27e9-f6fd80_800.png"},"title":"Use of \u00df2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease","link":"javascript:;","id":"item-271836"}]
